Archive

HIV Prevention Shot Lenacapavir: Aspen Warns of Demand Risks

Learn about the HIV prevention shot lenacapavir and why Aspen Pharmacare emphasises guaranteed demand for local production.

Read More

SA Professional Stress Index: A New Persistent Reality

The SA Professional Stress Index reveals a troubling reality of prolonged stress for professionals in South Africa. Learn more.

Read More

African Health Funding Shift: Nonprofits Battle Aid Declines

In East London, Lesley-Ann Foster is packing away decades of patient records. Her nonprofit, Masimanyane Women’s Rights International, is facing a crisis. This situation is becoming common across the continent. A massive shift in African health funding is fundamentally changing how medical services are delivered to the most vulnerable.

Read More

Afrigen Business Rescue: Cape Town Biotech Firm Seeks Investors

Cape Town biotech firm Afrigen’s business rescue begins as the WHO-backed mRNA hub seeks new investment to secure vaccine manufacturing.

Read More

NHI Act Implementation: Addressing Healthcare Gaps

The pause in NHI Act implementation opens a window to improve South Africa’s healthcare infrastructure. Discover its implications.

Read More

The Global Funding Crisis: Rebuilding Multilateral Institutions

Examine the consequences of the Global Funding Crisis on multilateral health institutions and their role in global health equity.

Read More

Health Department Suspensions Follow Senior Official’s Arrests

Health Minister Aaron Motsoaledi confirms suspensions in the Health Department after fraud arrests involving the Global Fund.

Read More

Aspen Pharmacare Asset Disposals: Future Opportunities

Learn about potential Aspen Pharmacare asset disposals aimed at optimising the company’s global operations for greater profitability.

Read More

Chronic Respiratory Diseases: A Silent Health Crisis

Across South Africa and the globe, a silent scourge is devastating public health. Chronic respiratory diseases (CRDs), including asthma and chronic obstructive pulmonary disease (COPD), remain significantly underreported. Despite their prevalence, they receive far less attention than infectious diseases.

Read More

GEMS Contribution Increases Spark Talks With Unions

The GEMS contribution increases have sparked tensions with public-sector unions. Discover the details surrounding this issue.

Read More

Generic Semaglutide Pricing Could Disrupt Global Markets

Discover the potential of Generic Semaglutide Pricing, where new research shows significant savings on weight-loss medications.

Read More

FDA Biosimilar Development Guidance Targets Treatment Costs

Learn how the new FDA biosimilar development guidance can significantly lower biologic medicine costs and improve accessibility.

Read More